Category: Genetics
Poster Session III
Maternal blood samples were submitted to Sequenom Laboratories, a Labcorp subsidiary, for NIPS. Fetal fraction (FF) calculation is described in Kim et al1. Chromosome Y fraction (YFF) is the proportion of the sample with cfDNA fragments mapping to unique regions of the Y chromosome. Sufficient chromosome Y detection is required for male sex reporting. Cases were identified via retrospective internal database search for reported fetal sex discrepancies between March 2015 and January 2022. Included cases had a vanished twin reported by the clinician, discordant fetal sex (male by NIPS, female by ultrasound), and submitted a repeat NIPS specimen.
Results:
49 cases met the above inclusion criteria. The average gestational age (GA) at initial screening was 11.7 weeks with repeat sampling 3.4 – 20.9 weeks later (mean & median: 9.6 weeks). The average FF and YFF at initial sampling were 9.9% and 2.3%, respectively, and 12.2% and 0.5% at resampling. YFF decreased in 96% of cases but was still detectable up to 14 weeks later. The average decrease in YFF was 0.2% per week.
Conclusion:
cfDNA contribution from a vanished twin is variable and influenced by the timing of the demise, reabsorption rates, and maternal physiology. Pre-test NIPS counseling in these pregnancies should include potential for sex discrepancy. In the absence of other fetal concerns repeat NIPS sampling at a later GA may be a reasonable first step in the context of a known vanished twin. The average change in YFF/week may guide time to resampling. Comparison of YFF to FF may be helpful in sex discrepant cases, particularly when early ultrasound data is limited.
Samantha Caldwell, MS, LCGC (she/her/hers)
LabCorp and Integrated Genetics
Winston Salem, North Carolina, United States
Brittany Dyr, MS
Integrated Genetics
Burlington, North Carolina, United States
Rebecca Jirik, BS
Augustana University
Sioux Falls, South Dakota, United States
Kimberly Fanelli, CGC,MS
Medical Science Liaison
Labcorp
Manchester, New Hampshire, United States
Philip Cacheris, MD, PhD
Integrated Genetics
San Diego, California, United States